T1	HMM 54 75	blood glucose control
T2	HMM 141 166	efficacy and tolerability
T3	HMM 788 837	postprandial glucose area under the curve AUC(0-2
T4	HMM 1033 1090	Postprandial AUC(0-2 h) of intact glucagon-like peptide-1
T5	HMM 1347 1359	Mean HbA(1c)
T6	HMM 1481 1496	DPP4 inhibition
T7	HMM 1639 1653	adverse events
T8	HMM 1851 1865	well tolerated
T9	HMM 1870 1901	improved blood glucose control.
